These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 30607326)

  • 41. Self-reported attitudes of elite athletes towards doping: differences between type of sport.
    Alaranta A; Alaranta H; Holmila J; Palmu P; Pietilä K; Helenius I
    Int J Sports Med; 2006 Oct; 27(10):842-6. PubMed ID: 16586338
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Clean Olympians? Doping and anti-doping: the views of talented young British athletes.
    Bloodworth A; McNamee M
    Int J Drug Policy; 2010 Jul; 21(4):276-82. PubMed ID: 20056401
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Survey of antidoping knowledge, attitudes and practices amongst elite Indian sportsmen and the way forward.
    Krishnan A; Datta K; Sharma D; Das Sharma S; Mahajan U; Jhajharia S; Yadav M
    Med J Armed Forces India; 2022 Jan; 78(1):88-93. PubMed ID: 35035049
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Should performance-enhancing drugs in sport be legalized under medical supervision?
    Wiesing U
    Sports Med; 2011 Feb; 41(2):167-76. PubMed ID: 21244107
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Doping].
    Kamber M; Villard G
    Praxis (Bern 1994); 1995 Sep; 84(36):970-7. PubMed ID: 7481289
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Adverse cardiovascular effects of doping in athletes.
    Tlili R; Zayed S; Saoudi W; Azaiez F; Hentati R; Ben Ameur Y
    Tunis Med; 2019 Nov; 97(11):1211-1218. PubMed ID: 32173820
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Anabolic steroid use: patterns of use and detection of doping.
    Graham MR; Davies B; Grace FM; Kicman A; Baker JS
    Sports Med; 2008; 38(6):505-25. PubMed ID: 18489196
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Sports physicians, ethics and antidoping governance: between assistance and negligence.
    Dikic N; McNamee M; Günter H; Markovic SS; Vajgic B
    Br J Sports Med; 2013 Jul; 47(11):701-4. PubMed ID: 23322892
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A forensic perspective of the AFL investigation into peptides: an antidoping investigation case study.
    Harcourt PR; Marclay F; Clothier B
    Br J Sports Med; 2014 May; 48(10):810-3. PubMed ID: 24642697
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Drug abuse in athletes.
    Reardon CL; Creado S
    Subst Abuse Rehabil; 2014; 5():95-105. PubMed ID: 25187752
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Strategies that athletes use to avoid detection of androgenic-anabolic steroid doping and sanctions.
    Alquraini H; Auchus RJ
    Mol Cell Endocrinol; 2018 Mar; 464():28-33. PubMed ID: 28130115
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Doping and sports].
    Lippi G; Guidi G
    Minerva Med; 1999 Sep; 90(9):345-57. PubMed ID: 10719440
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Qualitative and Semiquantitative Analysis of Doping Products Seized at the Swiss Border.
    Weber C; Krug O; Kamber M; Thevis M
    Subst Use Misuse; 2017 May; 52(6):742-753. PubMed ID: 28156209
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Doping and sports endocrinology: anabolic-androgenic steroids.
    García-Arnés JA; García-Casares N
    Rev Clin Esp (Barc); 2022 Dec; 222(10):612-620. PubMed ID: 36400345
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Doping Prevalence in Competitive Sport: Evidence Synthesis with "Best Practice" Recommendations and Reporting Guidelines from the WADA Working Group on Doping Prevalence.
    Gleaves J; Petróczi A; Folkerts D; de Hon O; Macedo E; Saugy M; Cruyff M
    Sports Med; 2021 Sep; 51(9):1909-1934. PubMed ID: 33900578
    [TBL] [Abstract][Full Text] [Related]  

  • 56. An update on regulatory issues in antidoping programs in sport.
    Hilderbrand RL; Wanninger R; Bowers LD
    Curr Sports Med Rep; 2003 Aug; 2(4):226-32. PubMed ID: 12834579
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Sport, Society, and Anti-Doping Policy: An Ethical Overview.
    Bloodworth AJ; McNamee M
    Med Sport Sci; 2017; 62():177-185. PubMed ID: 28571026
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effects of androgenic-anabolic steroids in athletes.
    Hartgens F; Kuipers H
    Sports Med; 2004; 34(8):513-54. PubMed ID: 15248788
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The analytical chemistry of drug monitoring in athletes.
    Bowers LD
    Annu Rev Anal Chem (Palo Alto Calif); 2009; 2():485-507. PubMed ID: 20636072
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Sports drug testing using complementary matrices: Advantages and limitations.
    Thevis M; Geyer H; Tretzel L; Schänzer W
    J Pharm Biomed Anal; 2016 Oct; 130():220-230. PubMed ID: 27040951
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.